Sera Prognostics SERA
NASDAQ SERA
$2.05 +0.06 (+2.76%)
At close: Aug 20, 2026 · 1:54 PM UTC

Sera Prognostics (SERA) Net Equity Issued and Repurchased (2020 - 2025)

Sera Prognostics' (SERA) quarterly Net Equity Issued and Repurchased came in at $53.6 million in Q1 2025, up 71580.0% on a QoQ basis from -$75000.0 in Q3 2021.

Sera Prognostics (SERA) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

Sera Prognostics (SERA) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $53.6 million in Q1 2025.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $53.6 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $53.6 million (changed N/A YoY) and the FY2025 annual result came in at $53.6 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased climbed to $53.6 million in Q1 2025, from -$75000.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $60.4 million in Q1 2021 to a low of -$75000.0 in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 199.44 Bn 193.84 Bn 7.27 Bn -
2 Stryker 127.32 Bn 123.85 Bn 4.50 Bn -
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn -
5 Edwards Lifesciences 51.90 Bn 47.65 Bn 1.35 Bn -
6 Dexcom 34.30 Bn 32.36 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.74 Bn 31.63 Bn 2.18 Bn -
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn -
9 Steris 23.05 Bn 22.56 Bn 684.20 Mn -
10 Sera Prognostics 103.23 Mn 103.23 Mn -20,000.00 -

Historic Data

Download Data
DateValue
Mar 31, 2025 53.61 Mn
Mar 31, 2025 53.61 Mn
Sep 30, 2021 -75,000.00
Sep 30, 2021 -75,000.00
Jun 30, 2021 38.64 Mn
Jun 30, 2021 38.64 Mn
Mar 31, 2021 60.42 Mn
Mar 31, 2021 60.42 Mn
Dec 31, 2020 19.60 Mn
Dec 31, 2020 19.60 Mn